Generated by AI
Summary of Nov 2's posts. Generated by AI.
Summary of Oct 30's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Summary of Oct 30's posts. Generated by AI.
Investors talking about GCTK also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
GlucoTrack Inc. is a medical technology company focused on diabetes monitoring solutions. GlucoTrack Inc. develops devices and systems designed to measure blood glucose levels for people living with diabetes, with an emphasis on continuous monitoring and reduced reliance on traditional finger-stick testing. Its current work centers on non-invasive glucose monitoring technology and an investigational long-term implantable continuous blood glucose monitor intended for ongoing glycemic tracking. The company’s products and development programs are aimed at supporting patients with Type 1 diabetes, insulin-dependent Type 2 diabetes, and prediabetes, while also serving clinicians who manage these conditions. GlucoTrack Inc. operates within the healthcare equipment and medical device market, where glucose monitoring tools play a critical role in daily diabetes care and disease management. The company is headquartered in Rutherford, New Jersey.
Website301 Route 17 North
Rutherford, NJ, 07070
United States
The latest articles about GCTK.
Detailed price information for Glucotrack Inc (GCTK) from The Globe and Mail including charting and trades.
Detailed price information for Glucotrack Inc (GCTK-Q) from The Globe and Mail including charting and trades.
Detailed price information for Glucotrack Inc (GCTK-Q) from The Globe and Mail including charting and trades.